Evidence map›Paper›PMID 42635826›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Virtual reality hypnosis during protective isolation: a parallel group randomized trial.

Anne-Violaine Doncker, Xavier Cahu, Benoit Bareau, Stéphanie Masset

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04794608 (Hypnosis in Virtual Reality in Patients in Protector Isolation Room for Aplasia in Clinical Hematology. Monocentric, Comparative, Randomized, Open Study.), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04794608 nacompletednot on this map

Hypnosis in Virtual Reality in Patients in Protector Isolation Room for Aplasia in Clinical Hematology. Monocentric, Comparative, Randomized, Open Study.

TypeinterventionalSponsorHôpital Privé SévignéRan2021 to 2024Enrolled60ConditionsAplasiaArmsHYPNO VR® device
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anne-Violaine DonckerClinical Hematology, Sévigné Private Hospital, Cesson-Sevigne, France.
Xavier CahuClinical Hematology, Sévigné Private Hospital, Cesson-Sevigne, France.
Benoit BareauClinical Hematology, Sévigné Private Hospital, Cesson-Sevigne, France.
Stéphanie MassetClinical Hematology, Sévigné Private Hospital, Cesson-Sevigne, France. s.masset@yahoo.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients in protective isolation often develop symptoms of anxiety. Virtual reality therapy and hypnosis could be of benefit to these patients, as both have been shown to relieve anxiety in a hospital setting. In this study, we investigated the use of virtual reality hypnosis (VRH), which induces a state of hypnosis. The primary aim was to determine whether VRH would reduce patients' anxiety during protective isolation. The secondary aim was to determine whether it would also relieve any pain.

methodsThis parallel group, open-label, single-center randomized trial included adult neutropenic patients who were about to undergo protective isolation within a hospital. The patients were randomly allocated, to receive either a 20-min session of VRH (n = 30) or a control activity (n = 30), for three days. The outcome measures included state anxiety from the state-trait anxiety inventory and pain on a visual analogue scale; these were assessed both before and after each session.

resultsThe state anxiety questionnaires could be scored for 58 patients on day 1, 40 on day 2, and 30 on day 3. The mean scores were found to fall following the VRH and control sessions. The reduction in S-anxiety was found to be significantly greater for the VRH group (-6.4 ± 9.6) than for the control group (-1.9 ± 5.3; p = 0.03). The pain ratings were low (< 2) and did not differ between the groups.

conclusionsThis study indicates that VRH is effective for reducing patients' anxiety during protective isolation, and may therefore be beneficial for patients.

trial registrationThis study was registered in Clinical Trials (NCT04794608, date of registration: 2021/03/03) and in ANSM (French drug regulator: 2020-A02561-38).

Indexed as

AnxietyHypnosisPatient IsolationVirtual RealityVirtual Reality Exposure TherapyAdultAgedFemaleHumansMaleMiddle AgedNeutropeniaPainPain MeasurementSurveys and QuestionnairesAnxietyHematological malignanciesProtective isolationVirtual reality hypnosis

Identifiers

PMID42635826
PMCPMC13503471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.